When prostate cancer strikes, one question is paramount: Is it aggressive and requiring immediate treatment, or slow-growing and worthy of monitoring only? Right now, an invasive biopsy is the ...
A prostate cancer biomarker test that utilizes 17 genetic markers has demonstrated a high degree of accuracy in screening for serious cancer. The test also significantly reduced unnecessary ...
Researchers at the University of Michigan Health Rogel Cancer Center have developed a new urine-based test that addresses a major problem in prostate cancer: how to separate the slow growing form of ...
Prostate-specific antigen, or PSA, remains the linchpin of prostate cancer detection. MPS2 improves upon a urine-based test developed by the same U-M team nearly a decade ago, following a landmark ...
THURSDAY, April 18, 2024 (HealthDay News) -- When prostate cancer strikes, one question is paramount: Is it aggressive and requiring immediate treatment, or slow-growing and worthy of monitoring only?
When a prostate-specific antigen blood test produces an abnormal result, the next step is usually a prostate biopsy. In April, researchers at the University of Michigan published results with a test ...
A urine test which looks at 18 genes linked to aggressive prostate cancer could help men with the slow-growing form of the disease avoid unnecessary invasive biopsies, according to scientists.
When prostate cancer strikes, one question is paramount: Is it aggressive and requiring immediate treatment, or slow-growing and worthy of monitoring only? Right now, an invasive biopsy is the only ...